Tag: cancer
-
Pioneering Targeted Therapies: Andarix Presents New Data on Radiopharmaceutical Innovations for Lung and Pancreatic Cancer
FOR IMMEDIATE RELEASE July 29, 2025 Contact: Andarix Pharmaceuticals 617-957-9858 info@andarix.com Driving New Partnerships and Investment Opportunities in Precision Oncology Radiopharmaceuticals Boston — At the 4th Targeted Radiopharmaceuticals Summit US, Andarix Pharmaceuticals is showcasing its pioneering targeted radiopharmaceutical technology for treating lung and pancreatic cancer. Company leadership is presenting recent data demonstrating how Andarix’s proprietary…
-
Andarix Pharmaceuticals CEO to Chair Radiopharmaceutical Conference
February 26, 2025 Targeted Radiotherapies: A New Approach to Treating Cancer Boston — ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for rare cancers, announced today that its CEO, Chris Adams, will chair a session at the targeted therapy conference in Boston. The conference will include attendees from industry experts…
-
Andarix Pharmaceuticals CEO to Groundbreaking Targeted Peptide Therapy at Clinical Trials Conference
October 23, 2024 Innovative Approach to Rare Cancer Treatment Attracts Attention from Industry Leaders and Patient Groups Boston — Andarix Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for rare cancers, announced today that its CEO, Chris Adams will present the two-day conference on outsourcing clinical trials. The conference will include…